An NIH-funded team has developed a miniature device with the potential to predict the therapeutic option that will work best for a given tumor, changing the narratives for the approximately 25,000 people diagnosed with brain cancers in the U.S. each year.
When implanted into cancerous brain tissue during surgery, the rice-sized drug-releasing device can simultaneously conduct experiments to measure a tumor’s response to more than a dozen drugs or drug combinations.
More on this remarkable device is available on NIH.gov.
Möchten Sie mehr über Änderungen der Vorschriften für Medizinprodukte erfahren? Nehmen Sie Kontakt mit den Experten von RegASK auf.